As part of execution of the decrees of the Russian Federation Government dd. September, 5, 2019 No. 1986-r and dd. September, 25 , 2019 No. 2170-r on the import of the unregistered medicinal products, containing psychotropic substances, on November 26, 2019, FSUE Moscow Endocrine Plant, which is under jurisdiction of the Ministry of Industry and Trade of Russia imported in full 3100 packs of Diazepam (trade name - Diazepam Desitin) in rectal solution dosage form - 5 mg/ 2.5 ml No. 5 and 10 mg/ 2.5 ml No. 5.
The product is intended for revealing paroxysmal syndrome in children with epilepsy.
Apart from the import of the required medicinal products to the Russian Federation, the work has been organised together with the Ministry of Health of Russia with regional healthcare bodies on the shipment of psychotropic medications to the subjects of the Russian Federation.
Donation (assignation) agreements were concluded with 45 subjects of the Russian Federation that notified about the necessity in Diazepam dosage forms unregistered in the Russian Federation.
The product Diazepam will be shipped in full by November 29, 2019 to the following subjects of the Russian Federation: the Altai Territory, the Belgorod Region, the Bryansk Region, the Voronezh Region, the Transbaikal Territory, the Ivanovo Region, the Kaliningrad Region, the Kemerovo Region, the Kostroma Region, the Krasnodar Territory, the Krasnoyarsk Territory, the Kursk Region, the Leningrad Region, Moscow, the Moscow Region, the Murmansk Region, the Nizhny Novgorod Region, the Novosibirsk Region, the Penza Region, the Perm Territory, the Altai Republic, the Republic of Buryatia, the Republic of Dagestan, the Republic of Karelia, the Republic of Mordovia, the Republic of North Ossetia, the Republic of Tatarstan, the Republic of Udmurtia, the Republic of Khakassia, the Rostov Region, the Samara Region, St. Petersburg, Sevastopol, the Smolenskaya Region, the Stavropol Territory, the Tambov Region, the Tver Region, the Tomsk Region, the Tyumen Region, the Ulyanovsk Region, the Chelyabinsk Region, the Chechen Republic, the Chuvash Republic, Yamalo-Nenets Autonomous Okrug, the Yaroslavl Region.
As part of the organisation of own production of the imported medicinal products, the Ministry of Industry and Trade of Russia together with the Enterprise has introduced medicinal products "Diazepam”, solution for rectal administration, 2.5 mg/1.25 ml, 5 mg/2.5 ml, 10 mg/2.5 ml, 20 mg/5 ml”.
The approximate term of start of own Diazepam production in rectal forms is QIV, 2020.
Earlier, FSUE Moscow Endocrine Plant imported 7 620 packs of Clobazam, as part of execution of the decrees of the Russian Federation Government.
Therefore, to this date, 10 720 packs out of the required 11 270 packs, approved by the decree of the Russian Federation Government have been imported.
Comment type is not specified in the component properties.